| was a professional and depth research report on China Influenza Vaccine Industry. Firstly the report describes the background knowledge of Influenza Vaccine， including Concepts Classification Manufacturing process technical parameters and equipments List etc； then statistics International and China 16 Manufacturers Influenza Vaccine product 2009-2017 Capacity production cost price production value profit margins and other relevant data， statistics these enterprises Influenza Vaccine products， Product Specifications， company background information， then summary statistics and analysis the relevant data on these enterprises. The report got Global and China Influenza Vaccine companies production market share， China Influenza Vaccine demand supply and shortage，？ China Influenza Vaccine 2009-2017 production price cost profit production value profit margins， production market share by different Sources（China Domestic and Imported etc） . At the same time， the report analyzed and discussed supply and demand changes in Influenza Vaccine market and business development strategies， conduct a comprehensive analysis on China Influenza Vaccine industry trends. Finally， the report also introduced 8Million Pieces/year Influenza Vaccine project Feasibility analysis and related research conclusions. In a word， It was a depth research report on China Influenza Vaccine industry. And thanks to the support and assistance from Influenza Vaccine industry chain related experts and enterprises during Research Team survey and interview. | |
Chapter One Influenza Vaccine Industry Overview |
|
1.1 Definition |
|
1.2 Classification |
|
| 1.2.1 Seasonal Influenza Vaccine | |
| 1.2.2 Type A H1N1 Influenza Vaccine | |
| 1.2.3 Two Type Influenza Vaccine Comparison | |
1.3 Vaccine Inoculation |
|
1.4 Industry Chain Structure |
|
1.5 Influenza Vaccine Development Prospect |
|
| 1.5.1 United States Overplus | |
| 1.5.2 Seek Competitive Differentiation New Technology Prevalence | |
| 1.5.3 Huge Market Demand in China | |
Chapter Two Influenza Vaccine Manufacturing Technology and Process |
|
2.1 Influenza Vaccine Manufacturing Technology Overview |
|
| 2.1.1 Embryo Culture Type A H1N1 Influenza Vaccine Manufacturing Process | |
| 2.1.2 Vero Cell Culture Inactivated Influenza Vaccine Manufacturing Process | |
2.2 Comparison of Two Procee Method |
|
| 2.2.1 Embryo Culture Inactivated Influenza Vaccine Process Flow | |
| 2.2.2 Cell Culture Inactivated Influenza Vaccine Process Flow | |
| 2.2.3 Two Manufacturing Process Comparison | |
| 詳^情：http://www.htout.com/2014-01/2014_Deep_Research_Report_on_China_Influenza_Vaccine_Industry/ | |
2.3 Influenza Vaccine Manufacturing Equipments List |
|
2.4 Influenza Vaccine Manufacturing Process Today and Tomorrow |
|
| 2.4.1 Influenza Vaccine Manufacturing Process Status | |
| 2.4.2 H1N1 Influenza Vaccine Manufacturing Process Problems | |
| 2.4.3 Influenza Vaccine New Manufacturing Technology | |
Chapter Three Influenza Vaccine？ Production Supply Sales Demand Market Status and Forecast |
|
3.1 Influenza Vaccine Productions Overview |
|
3.2 Influenza Vaccine Demand Overview |
|
3.4 Influenza Vaccine Cost Price Production Value Gross Margin |
|
Chapter Four Influenza Vaccine Key Manufacturers |
|
4.1 Hualan Bio （Henan） |
|
4.2 Sinovac （Beijing） |
|
4.3 Tianyuan Bio-pharma （Zhejiang） |
|
4.4 Changsheng （Jilin Changchun） |
|
4.5 Aleph Biomedical （Liaoning） |
|
4.6 SIOBP （Shanghai） |
|
4.7 CCBIO （Jilin Changchun） |
|
4.8 Lanzhou Institute of Biological Products （Qinghai） |
|
4.9 Tiantan Biological （Beijing） |
|
4.10 Sanofi-pasteur （France） |
|
4.11 GSK （UK） |
|
4.12 Novartis （Switzerland） |
|
4.13 Abbott （US） |
|
4.14 Crucell （Holland） |
|
4.15 Tasly&Jenner （Tianjin） |
|
4.16 Neptunus Interlong （Shenzhen） |
|
Chapter Five China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis |
|
5.1 China 8Million Pieces/Year Influenza Vaccine Project Opportunities and Risks Analysis |
|
| 5.1.1 Opportunities | |
| 5.1.2 Risks | |
5.3 China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis |
|
| 5.3.1 Project Overview | |
| 5.3.2 Capacity | |
| 5.3.3 Construction Standards | |
| 5.3.3 Construction Period | |
| 5.3.4 Project Schedule | |
| 5.3.5 Investment Feasibility Analysis | |
Chapter Six Influenza Vaccine Industry Research Conclusions |
|
| Tables and Figures | |
| Table Common Vaccines Classification | |
| Table United States Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List | |
| Table Europe Approval Type A influenza H1N1 Vaccine Suppliers and Product Specifications List | |
| Table China First Type Vaccine and Second Type Vaccine Classification and Application | |
| 2014 Deep Research Report on China Influenza Vaccine Industry | |
| Table First Type Vaccine and Second Type Vaccine Detail Market Analysis | |
| Table 2009-2013 China First Type Vaccine and Second Type Vaccine Issue Number （10K Pieces） and Market Share | |
| Figure 2013 State-owned Private Foreign Enterprise Market Share in First Type Vaccine and Second Type Vaccine | |
| Figure Influenza Vaccine Industry Chain Structure | |
| Figure Vaccine Cold Chain Circulation System | |
| Figure Vaccine Transportation Model | |
| Figure First Type Vaccine Transportation Channel | |
| Figure Second Type Vaccine Transportation Channel | |
| Figure Vaccine Transportation Steps and Process | |
| Figure 2009-2019 Global Influenza Vaccine Market Scale（100 Million USD） | |
| Figure 2013 United States TOP5 Suppliers Influenza Vaccine Market Share | |
| Figure China Influenza Vaccine Inoculation Coverage Rate and Its Gap to International Goal | |
| Table Baxter Vero Cell Platform Background Information | |
| Figure Embryo Culture Inactivated Vaccine Manufacturing Process Flow | |
| Figure Cell Culture Inactivated Influenza Vaccine Manufacturing Process Flow | |
| Figure Two Influenza Vaccine Manufacturing Process Comparison | |
| Figure Influenza Vaccine Manufacturing Steps | |
| Figure Influenza Vaccine Detection Steps | |
| Table Influenza Vaccine Manufacturing Equipments List （38 Equipments） | |
| Figure Influenza Vaccine Production Periodic Table | |
| Figure Influenza Vaccine Production schedules | |
| Table Influenza Vaccine Development History | |
| Table Existing and R&D Influenza Vaccine Products List | |
| Figure Influenza Vaccine New Manufacturing Technology | |
| Table China 11 Manufacturers Influenza Vaccine Market Status List | |
| Table Selling Influenza Vaccine in China 5 Foreign Suppliers List | |
| Table 2009-2017 China 11 Manufacturers Influenza Vaccine Capacity and Total Capacity （10K Pieces） List | |
| Table 2009-2017 China 11 Manufacturers Influenza Vaccine Capacity Market Share List | |
| Table 2009-2017 China 11 Manufacturers Influenza Vaccine Production and Total Production （10K Pieces） List | |
| Table 2009-2017 China 11 Manufacturers Influenza Vaccine Production Market Share List | |
| Table 2009-2017 China Influenza Vaccine Capacity Production （10K Pieces） and Capacity Utilization Rate | |
| Figure 2009-2017 China Influenza Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Figure 2013 China Key Manufacturers Influenza Vaccine Production Market Share （China Government Approcal Data） | |
| Table 2009-2017 Global Key Suppliers Influenza Vaccine Capacity and Total Capacity （100 Million Pieces） List | |
| Table 2009-2017 Global Key Suppliers Influenza Vaccine Production and Total Production （100 Million Pieces） List | |
| Figure 2009-2017 Global Influenza Vaccine Capacity Production （100 Million Pieces） and Growth Rate | |
| Table 2009-2017 Global Influenza Vaccine Capacity Production （100 Million Pieces） and Capacity Utilization Rate | |
| Figure 2011 Global Key Suppliers Influenza Vaccine Production Market Share | |
| Table 2009-2017 Global Key Suppliers Influenza Vaccine China Sales （10K Pieces） List | |
| Figure 2013 China Imported Influenza Vaccine Market Share By Suppliers （China Government Approval Data） | |
| Table Global and China Key Suppliers Key Vaccine Products Sales in China | |
| Table 2007-2011 China Influenza Vaccine Approval Amount by Suppliers （10K Pieces） | |
| Figure 2013 China Influenza Vaccine Market Share by Splitting Vaccine and Subunit Vaccine （according China government approval amount） | |
| 2014 Deep Research Report on China Influenza Vaccine Industry | |
| Table 2009-2017 China local Influenza Vaccine and Imported Influenza Vaccine Market Share Comparison | |
| Table 2001-2020 China Birth Rate and Population （10K） | |
| Figure China India Korea Japan etc 9 Countries Child Mortality （‰） | |
| Table 2000-2050 China Age Over 60 Population （100 Million） and Proportion （%） | |
| Figure 2010-2050 China Age Over 60 Over 65 Over 80 Population Proportion | |
| Table 2001-2015 China Per Capita GDP （USD） and Growth Rate | |
| Figure 2009-2017 China Influenza Vaccine Supply Demand （10K Pieces） and Growth Rate | |
| Figure China Japan France etc 9 Countries Age Over 65 Population Influenza Vaccine Inoculation Coverage Rate | |
| Table 2009-2017 China Influenza Vaccine Supply Demand and Shortage （10K Pieces） | |
| Table 2013 Hangzhou Disease Control and Prevention Center 33 Type Influenza Vaccine Products Purchase and Selling Price （RMB/Piece） | |
| Table 2013 China and Imported Influenza Vaccine Capacity Production （10K Pieces） Price Cost Profit （RMB/Piece） Gross Margin List | |
| Table 2009-2017 China Influenza Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Table Hualan Bio Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Hualan Bio Vaccine Factory Picture | |
| Figure Hualan Bio Influenza Virus Split Vaccine （Childhood Type） | |
| Figure Hualan Bio Influenza Virus Split Vaccine （Adult Type） | |
| Figure Hualan Bio Type A H1N1 Influenza Virus Split Vaccine | |
| Table 2009-2017 Hualan Bio Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Hualan Bio Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table Sinovac Biotech Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Table Sinovac Biotech Vaccine Plant Picture | |
| Table Sinovac Biotech Development History Time Table | |
| Figure Sinovac Biotech Influenza Virus Split Vaccine-Anrlaifu | |
| Figure Sinovac Biotech Pandemic Influenza Virus Inactivated Vaccine - Panrlaifu | |
| Figure Sinovac Biotech Type A H1N1 Influenza Virus Split Vaccine - Panrlaifu.1 | |
| Table 2009-2017 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Sinovac Biotech Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table Tianyuan Bio-pharma Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Tianyuan Bio-pharma Influenza Vaccine Products List | |
| Figure Tianyuan Bio-pharma Influenza Virus Split Vaccine - Yuganning | |
| Table 2009-2017 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Tianyuan Bio-pharma Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table Changsheng Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Changsheng Influenza Virus Split Vaccine - Wanxin | |
| Figure Changsheng Type A H1N1 Influenza Virus Split Vaccine | |
| Table 2009-2017 Changsheng Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Changsheng Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table Aleph Biomedical Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Table Aleph Biomedical Contact Information List | |
| Figure Aleph Biomedical Influenza Vaccine Manufacturing Workshop | |
| 2014 Deep Research Report on China Influenza Vaccine Industry | |
| Figure Aleph Biomedical Influenza Virus Split Vaccine（Adult Type） | |
| Figure Aleph Biomedical Influenza Virus Split Vaccine （Childhood Type） | |
| Table 2009-2017 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Aleph Biomedical Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table SIOBP （Shanghai Institute of Biological Products） Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure CNBG and Six Institutes Equity Relationship | |
| Figure SIOBP Influenza Virus Split Vaccine | |
| Figure SIOBP Type A H1N1 Influenza Virus Split Vaccine | |
| Table 2009-2017 SIOBP Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 SIOBP Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table CCBIO（Changchun Institute of Biological Products） Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure CCBIO Influenza Split Vaccine - Shipulir | |
| Figure CCBIO Factory Workshop Picture | |
| Table 2009-2017 CCBIO Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 CCBIO Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table Lanzhou Institute of Biological Products Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Lanzhou Institute of Biological Products Factory Picture | |
| Table Lanzhou Institute of Biological Products Trivalent Influenza Split Vaccine | |
| Table 2009-2017 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Lanzhou Institute of Biological Products Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table Tiantan Biological Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Tiantan Biological Control Shares of Sinopharm | |
| Figure Tiantan Biological and Related Control Subsidiaries Relationship | |
| Figure Tiantan Biological Factory Picture | |
| Figure Tiantan Biological Beijing Yizhuang Vaccine Plants Picture | |
| Figure Tiantan Biological Type A H1N1 Influenza Virus Split Vaccine | |
| Figure Tiantan Biological Influenza Virus Split Vaccine | |
| Table 2009-2017 Tiantan Biological Influenza Virus Split Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Tiantan Biological Influenza Virus Split Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table Sanofi-pasteur Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Sanofi-pasteur China Pharmaceutical Factories Distribution | |
| Figure Influenza Virus Split Vaccine-Fanrling | |
| Table 2009-2017 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production （100Million Pieces） China Sales （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Sanofi-pasteur Influenza Virus Split Vaccine Capacity Production （100Million Pieces） and Growth Rate | |
| Table GSK Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure GSK Shenzhen Influenza Vaccine Workshop Pictures | |
| Figure GSK Influenza Split Vaccine - Fluarix | |
| Table 2009-2017 GSKInfluenza Virus Split Vaccine Capacity Production （100Million Pieces） China Sales （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 GSKInfluenza Virus Split Vaccine Capacity Production （100Million Pieces） and Growth Rate | |
| Table Novartis Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Novartis Subunit Influenza Vaccine - Agrippal | |
| Figure Novartis Aged Population Special Use Influenza Vaccine - Fluad | |
| 中國インフルエンザワクチン産業上の2014ディープ研究報告 | |
| Table 2009-2017 Novartis Influenza Virus Subunit Vaccine Capacity Production （100Million Pieces） China Sales （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Novartis Influenza Virus Subunit Vaccine Capacity Production （100Million Pieces） and Growth Rate | |
| Table Abbott Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Abbott Influenza Subunit Vaccine - Influvac | |
| Table 2009-2017 Abbott Subunit Influenza Vaccine Capacity Production （100Million Pieces） China Sales （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Figure 2009-2017 Abbott Subunit Influenza Vaccine Capacity Production （100Million Pieces） and Growth Rate | |
| Table Crucell Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Table Crucell Selling Vaccines and R&D Projects List | |
| Table Crucell V Type Virion Adjuvant Influenza Vaccine （Subunit ） - Inflexal | |
| Table 2009-2017 Crucell Subunit Influenza Vaccine Capacity Production （100Million Pieces） China Sales （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Table 2009-2017 Crucell Subunit Influenza Vaccine Capacity Production （100Million Pieces） and Growth Rate | |
| Table Tasly&Jenner Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Tasly&Jenner Factory Pictures | |
| Figure Tasly&Jenner Subunit Influenza Virus Split Vaccine-Fuluoke？ | |
| Table 2009-2017 Tasly&Jenner？ Influenza Virus Subunit Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Table 2009-2017 Tasly&Jenner Influenza Virus Subunit Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table Neptunus Interlong Company Information Table（Products Development History Location Background Contact Information etc 14 Items） | |
| Figure Neptunus Interlong Vaccine Factory Picture | |
| Figure Neptunus Interlong Vaccine Workshop Picture | |
| Figure Neptunus Interlong Influenza Subunit Vaccine Package | |
| Table 2009-2017 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production （10K Pieces） Price Cost Gross （RMB/Piece） Production Value （10K RMB） Gross Margin List | |
| Table 2009-2017 Neptunus Interlong Influenza Virus Subunit Vaccine Capacity Production （10K Pieces） and Growth Rate | |
| Table China 8Million Pieces/Year Influenza Vaccine Project Investments List | |
| Table China 8Million Pieces/Year Influenza Vaccine Project Investment Feasibility Analysis | |
http://www.htout.com/2014-01/2014_Deep_Research_Report_on_China_Influenza_Vaccine_Industry/
略……
如需購買《2014 Deep Research Report on China Influenza Vaccine Industry》，編號：133A662
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
請您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網上訂購】 ┊ 下載《訂購協議》 ┊ 了解“訂購流程”
京公網安備 11010802027365號